door Oxilary | jan 8, 2021 | Medicijnen, Onderzoek, Zorg
The Plan To End Cancer: One-on-one with Sean Parker Sean Parker, founder and chairman of the Parker Institute for Cancer Immunotherapy discusses his $250 million investment in the development of new technologies to combat cancer and examines which fields of research...